Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Galli and Stefano Rusconi.
Connection Strength
1.836
-
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427.
Score: 0.226
-
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey. JMIR Public Health Surveill. 2020 09 18; 6(3):e21866.
Score: 0.226
-
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
Score: 0.224
-
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
Score: 0.221
-
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
Score: 0.220
-
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. J Med Virol. 2020 Sep; 92(9):1637-1640.
Score: 0.219
-
Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan, Italy. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):315-321.
Score: 0.181
-
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021 06; 3(6):774-785.
Score: 0.059
-
Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy. Pathogens. 2021 Feb 23; 10(2).
Score: 0.058
-
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care. 2020 12; 43(12):2999-3006.
Score: 0.057
-
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis. 2018 Nov 12; 18(1):556.
Score: 0.050
-
Clinical and genetic determinants of nevirapine plasma trough concentration. SAGE Open Med. 2018; 6:2050312118780861.
Score: 0.048
-
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial. New Microbiol. 2018 Apr; 41(2):106-111.
Score: 0.047